Evidence map›Paper›PMID 23814078›Full record

ArticleThe Journal of biological chemistry2013

Cell cycle-dependent subcellular translocation of the human DNA licensing inhibitor geminin.

Maria Dimaki, Georgia Xouri, Ioanna-Eleni Symeonidou, Chaido Sirinian, Hideo Nishitani, Stavros Taraviras, Zoi Lygerou

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. A Custom Ultra-Low-Cost 3D Bioprinter Supports Cell Growth and Differentiation.Frontiers in bioengineering and biotechnology · 2020
    Article
  5. Review
  6. Review
  7. Mechanisms and regulation of DNA replication initiation in eukaryotes.Critical reviews in biochemistry and molecular biology · 2017
    Review
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Maria DimakiLaboratory of General Biology, School of Medicine, University of Patras, 26500 Rio, Patras, Greece.
Georgia Xouri
Ioanna-Eleni Symeonidou
Chaido Sirinian
Hideo Nishitani
Stavros Taraviras
Zoi Lygerou
University of Patras · GRUniversity of Hyogo · JP

Funding

Worldwide Cancer Research 09-0091
6 · The paper itself

Abstract

Once per cell cycle replication is crucial for maintaining genome integrity. Geminin interacts with the licensing factor Cdt1 to prevent untimely replication and is controlled by APC/C-dependent cell cycle specific proteolysis during mitosis and in G1. We show here that human geminin, when expressed in human cells in culture under a constitutive promoter, is excluded from the nucleus during part of the G1 phase and at the transition from G0 to G1. The N-terminal 30 amino acids of geminin, which contain its destruction box, are essential for nuclear exclusion. In addition, 30 amino acids within the central domain of geminin are required for both nuclear exclusion and nuclear accumulation. Cdt1 overexpression targets geminin to the nucleus, while reducing Cdt1 levels by RNAi leads to the appearance of endogenous geminin in the cytoplasm. Our data propose a novel means of regulating the balance of Cdt1/geminin in human cells, at the level of the subcellular localization of geminin.

Indexed as

Cell CycleDNA ReplicationCell Cycle ProteinsCell NucleusG1 PhaseGemininGreen Fluorescent ProteinsHumansMCF-7 CellsModels, BiologicalMutant ProteinsMutationProtein BindingProtein TransportRecombinant Fusion ProteinsSubcellular FractionsCDT1 protein, humanCell Cycle ProteinsGemininGMNN protein, humanGreen Fluorescent ProteinsMutant ProteinsRecombinant Fusion ProteinsCdt1Cell CompartmentationCell CycleDNA ReplicationGemininGenome StabilityGenomic InstabilityLicensingNuclear ExclusionNuclear Transport

Identifiers

PMID23814078
PMCPMC3745341
OpenAlexW2014869206

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.